Prestige Consumer Healthcare (Prestige Consumer Healthcare) Short-Term Debt & Capital Lease Obligation : $8 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Prestige Consumer Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $8 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Prestige Consumer Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1,206 Mil.

Prestige Consumer Healthcare Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Prestige Consumer Healthcare's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Consumer Healthcare Short-Term Debt & Capital Lease Obligation Chart

Prestige Consumer Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

6.83

8.45

9.11

9.76

Prestige Consumer Healthcare Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															9.67	9.76	9.46	9.61	7.84

Prestige Consumer Healthcare Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Prestige Consumer Healthcare Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Consumer Healthcare (Prestige Consumer Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (NYSE:PBH) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

PBV:Germany

Address

660 White Plains Road, Tarrytown, NY, USA, 10591

Website

https://www.prestigebrands.com

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Executives

Mary Beth Fritz	officer: Senior VP Quality & Regulatory	660 WHITE PLAINS RD, 2ND FL, TARRYTOWN NY 10591
Ronald M. Lombardi	officer: Chief Executive Officer	660 WHITE PLAINS RD., TARRYTOWN NY 10591
James Darecca	director	C/O HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110
Christine Sacco	officer: Chief Financial Officer	C/O SMART BALANCE, INC., 115 WEST CENTURY ROAD, SUITE 260, PARAMUS NJ 07652
Adel Mekhail	other: EVP, Marketing & Sales	660 WHITE PLAINS RD., 2ND FL, TARRYTOWN NY 10591
William P'pool	officer: See Remarks	2400 WEST LLOYD EXPRESSWAY, EVANSVILLE IL 47721
Celeste A. Clark	director	C/O ADVANCEPIERRE FOODS HOLDINGS, INC., 9987 CARVER ROAD, BLUE ASH OH 45242
Christopher J Coughlin	director
Natale S Ricciardi	director	C/O MORRIS COMMUNICATIONS CORP, 725 BROAD ST., AUGUSTA GA 30903
James M Jenness	director	PO BOX 3599, BATTLECREEK MI 49016-3599
John E Byom	director	660 WHITE PLAINS RD., TARRYTOWN NY 10591
Sheila Hopkins	director	C/O WARNACO INC, 90 PARK AVENUE, NEW YORK NY 10016
Dawn M. Zier	director	600 OFFICE CENTER DRIVE, FORT WASHINGTON PA 19034
Jeffrey Zerillo	officer: Senior VP Operations	660 WHITE PLAINS RD, 2ND FL, TARRYTOWN NY 10591
Timothy Connors	officer: Chief Marketing Officer	660 WHITE PLAINS RD., SUITE 205, TARRYTOWN NY 10591